Tango Therapeutics announced an expansion of its management team with the promotion of Alan Huang, Ph.D., to chief scientific officer and the addition of Charles Davis, Ph.D., as senior vice president, pharmaceutical sciences. “We are thrilled to have Alan leading our scientific efforts. His wealth of experience in oncology research and his strategic approach to building Tango’s target and drug discovery platform will help us in our drive to get important new drugs to the patients who need t...